AWM
PRQR icon

Activest Wealth Management’s ProQR Therapeutics PRQR Stock Holding History

Activest Wealth Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$213 – 1272
2025
Q3 		$213 Hold
100
– – ﹤0.01% 1019
2025
Q2 		$204 Hold
100
– – ﹤0.01% 946
2025
Q1 		$133 Buy
+100
New +$213 ﹤0.01% 951

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Activest Wealth Management's PRQR Position: Q4 2025 in Review

Activest Wealth Management sold out of ProQR Therapeutics (PRQR) in Q4 2025, closing a stake of 100 shares — an estimated $213 sold.

Activest Wealth Management first reported a position in PRQR in Q1 2025 and held it in 3 quarters. The position peaked at $213 in Q3 2025. 65 funds tracked by Wall St. Rank hold PRQR as of Q4 2025.

  • Activest Wealth Management reported no remaining ProQR Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Activest Wealth Management sold 100 ProQR Therapeutics shares in Q4 2025, an estimated $213.
  • Activest Wealth Management first reported a position in ProQR Therapeutics in Q1 2025 and held it in 3 quarters.
  • Activest Wealth Management's ProQR Therapeutics position peaked at $213 in Q3 2025.
  • 65 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2025.

Based on Activest Wealth Management's 13F filing for Q4 2025, filed 30 Jan 2026.